Live Breaking News & Updates on Giles Platford

Stay updated with breaking news from Giles platford. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

A Decade Of Innovation: How This CEO Transformed A Global Pharma Giant

In a decade, Christophe Weber remade Takeda into a global pharma leader, shifting from a fragmented structure to a unified innovator. ....

United States , United Kingdom , Christophe Weber , Giles Platford , Julie Kim , Pallavi Garg , Takeda Qdenga , Takeda Pharmaceutical , Plasma Derived Therapies , Emerging Markets , Global Oncology Products , Narcolepsy Type , Plaque Psoriasis , Health Care , Life Sciences , Rare Disease , Takeda Pharmaceuticals , Big Pharma ,

Takeda's HyQvia receives EC approval for rare neuromuscular disorder CIDP

Takeda's HyQvia receives EC approval for rare neuromuscular disorder CIDP
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Kristina Allikmets , Giles Platford , Takeda Hyqvia , European Commission , Drug Administration , Plasma Derived Therapies Business Unit ,

FDA approves Hyqvia for chronic inflammatory demyelinating polyneuropathy

FDA approves Hyqvia for chronic inflammatory demyelinating polyneuropathy
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Halozyme Enhanze , Giles Platford , Caroll Diberardino , Takeda Pharmaceutical ,

Takeda's HyQvia granted FDA approval to treat rare neuromuscular disorder CIDP

Takeda's HyQvia granted FDA approval to treat rare neuromuscular disorder CIDP
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Elisa Butler , Takeda Hyqvia , Giles Platford , Foundation International , Drug Administration , Plasma Derived Therapies Business Unit ,

FDA Approves IgG-Hyaluronidase Recombinant for the Treatment of Adult Patients With CIDP

Previously, IgG-hyaluronidase recombinant was approved by the FDA in 2014 for the treatment of primary immunodeficiency in adult patients and has expanded to include some pediatric patients. ....

Elisa Butler , Giles Platford , Foundation International , Plasma Derived Therapies Business Unit ,